Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study

Table 2 Key model input parameters for the four settings, stratified by vaccine serotypes (VT) and non-vaccine serotypes (NVT) where appropiate

	Age	Population	Carriage prevalence		Sample size	Clearance rate
	Age	Population	VT	NVT	Sample size	VT	NVT
E&W	< 1 year	629,200	0.43	0.12	51	0.014	0.014
	1–5 years	3,009,200	0.25	0.15	138	0.029	0.029
	6–14 years	5,999,000	0.08	0.10	52	0.056	0.056
	15–20 years	4,132,900	0.00	0.13	8	0.057	0.057
	21–49 years	21,368,700	0.00	0.02	232	0.059	0.059
	50+	17,905,900	0.00	0.00	2	0.059	0.059
Kilifi	< 1 year	9617	0.41	0.46	39	0.009	0.012
	1–5 years	45,170	0.34	0.44	127	0.020	0.023
	6–14 years	68,547	0.15	0.39	82	0.049	0.050
	15–20 years	33,289	0.14	0.25	56	0.049	0.050
	21–49 years	72,143	0.07	0.22	97	0.049	0.050
	50+	24,214	0.04	0.20	104	0.049	0.050
Finland	< 1 year	56,748	0.12	0.05	400	0.022	0.022
	1–5 years	284,828	0.24	0.10	412	0.022	0.022
	6–17 years	764,192	0.08	0.03	86	0.033	0.033
	18+	4,130,843	0.02	0.01	263	0.033	0.033
Nha Trang	< 1 year	2094	0.27	0.07	41	0.014	0.014
	1–5 years	15,239	0.25	0.20	63	0.029	0.029
	6–17 years	40,324	0.02	0.09	55	0.056	0.056
	18–49 years	115,538	0.01	0.01	262	0.059	0.059
	50+	37,544	0.01	0.01	98	0.059	0.059

ISSN: 1741-7015